Skip to main content
. 2018 Nov 21;1(7):e184909. doi: 10.1001/jamanetworkopen.2018.4909

Table 3. Cumulative Incidence of Selected Types of Cancer After First Hospital-Based Hematuria Diagnosis.

Cancer Type 3 mo After Diagnosis, % (95% CI) 1 y After Diagnosis, % (95% CI) 5 y After Diagnosis, % (95% CI)
Any cancer 4.81 (4.70-4.93) 6.65 (6.51-6.78) 12.34 (12.15-12.53)
Women 2.76 (2.63-2.91) 4.02 (3.85-4.19) 8.62 (8.36-8.88)
Men 6.12 (5.96-6.29) 8.32 (8.13-8.52) 14.69 (14.43-14.95)
Urologic cancers
Invasive bladder 1.98 (1.91-2.06) 2.26 (2.18-2.34) 2.55 (2.47-2.64)
Noninvasive bladder 0.81 (0.76-0.86) 0.93 (0.88-0.98) 1.08 (1.02-1.13)
Kidney 0.43 (0.39-0.46) 0.52 (0.48-0.56) 0.66 (0.61-0.70)
Renal pelvic 0.15 (0.13-0.17) 0.20 (0.17-0.22) 0.26 (0.23-0.29)
Ureteral 0.05 (0.04-0.06) 0.07 (0.06-0.08) 0.09 (0.08-0.11)
Prostate (in men) 1.11 (1.04-1.19) 1.59 (1.50-1.67) 2.87 (2.73-2.98)
Gynecologic cancers (in women)
Uterine 0.08 (0.05-0.10) 0.15 (0.13-0.20) 0.33 (0.28-0.38)
Cervical 0.05 (0.03-0.08) 0.05 (0.03-0.08) 0.08 (0.05-0.13)
Ovarian 0.05 (0.03-0.05) 0.06 (0.05-0.08) 0.15 (0.13-0.20)
Abdominal cancers
Colon 0.09 (0.08-0.11) 0.16 (0.14-0.19) 0.50 (0.46-0.54)
Rectal 0.04 (0.03-0.05) 0.07 (0.06-0.09) 0.24 (0.21-0.27)
Liver 0.02 (0.01-0.03) 0.03 (0.02-0.04) 0.10 (0.08-0.11)
Hematologic cancers
Leukemia 0.02 (0.02-0.03) 0.05 (0.04-0.07) 0.19 (0.16-0.21)
Non-Hodgkin lymphoma 0.05 (0.03-0.06) 0.08 (0.07-0.10) 0.21 (0.18-0.23)
Multiple myeloma 0.03 (0.02-0.04) 0.05 (0.04-0.06) 0.11 (0.09-0.13)